Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Research & Development

Navitas Brings End-to-End R&D Solutions to the Generic Drug Industry

Research & Development
Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver "first to file" results to generic drug companies around the globe,...

Surge in RNAscope and BaseScope Assay publications now includes pharma, biotech and new research areas – and use as a core assay

Research & Development
Advanced Cell Diagnostics (ACD), a Bio-Techne brand, is celebrating a milestone in the adoption of its RNAscope® in situ hybridization (ISH) technology. Reaching 1,000...

Median Technologies inks a collaboration agreement with Memorial Sloan Kettering Cancer Center for a study dealing with prostate cancer

Research & Development
Median Technologies, The Imaging Phenomics Company® (Paris:ALMDT) announces today that the company has signed a collaboration agreement with the New York City based Memorial...

Synpromics announces collaboration with UCL to develop revolutionary gene therapy for Parkinson’s Disease

Manufacturing
Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system...

Biogen and Alkermes Announce License and Collaboration Agreement to Develop and Commercialize ALKS 8700 for the Treatment of Multiple Sclerosis

Research & Development
Biogen and Alkermes plc announced that they have entered into a global license and collaboration agreement to develop and commercialize ALKS 8700, a novel,...

Receptor tyrosine kinase-like orphan receptor 1-derived peptide as target for the design of cytotoxic T cell-based immunotherapy

Research & Development
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in adults. It is due to the growth of neoplastic B cells in...

AstraZeneca and Chinese Future Industry Investment Fund establish joint venture to develop new medicines in China

Research & Development
AstraZeneca announced a strategic joint venture with the Chinese Future Industry Investment Fund (FIIF) to form an equally-owned, stand-alone company in China to discover,...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.